Candidates are determined through medical evaluation
These data were first presented by Amanda Johnson, MD, Mayo Clinic, Rochester, Minnesota, at the 2026 Crohns and Colitis Congress on Friday, January 23, 2026, in Las Vegas, Nevada
Efficacy and pharmacokinetics of subcutaneous exendin (939) in patients with post-bariatric hypoglycaemia
Key Research Applications Tendon and connective tissue repair: The BPC-157 TB-500 blend provides both localized fibroblast stimulation via BPC-157 and systemic cell migration via TB-500, making it a powerful dual-pathway tool for tendon injury research
The mucoprotein molecule secreted by the gastric mucosal cells and required for the absorption of vitamin B12 into the body